Log in
TSE:HBP

Helix BioPharma Corp. (HBP.TO) Stock Forecast, Price & News

C$0.29
-0.03 (-9.38 %)
(As of 12/1/2020 12:00 AM ET)
Add
Compare
Today's Range
C$0.29
Now: C$0.29▼
C$0.30
50-Day Range
C$0.30
MA: C$0.33▼
C$0.40
52-Week Range
C$0.28
Now: C$0.29▼
C$2.01
Volume79,643 shs
Average Volume13,572 shs
Market CapitalizationC$38.55 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with ProMab Biotechnologies, Inc. to develop novel antibody and chimeric antigen receptor T-cell therapy to treat multiple myeloma, as well as a license agreements with Xisle Pharma Ventures Trust and National Research of Council Canada. The company is headquartered in Richmond Hill, Canada.

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.46 out of 5 stars


Industry, Sector and Symbol

Stock Exchange TSE
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolTSE:HBP
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.helixbiopharma.com
Phone+1-416-9253232
Employees22

Debt

Debt-to-Equity Ratio5.33
Current Ratio2.42
Quick Ratio2.29

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowC$0.03 per share
Price / Cash Flow9.69
Book ValueC$0.02 per share
Price / Book16.11

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares132,933,000
Market CapC$38.55 million
Next Earnings Date12/11/2020 (Estimated)
OptionableOptionable
C$0.29
-0.03 (-9.38 %)
(As of 12/1/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HBP News and Ratings via Email

Sign-up to receive the latest news and ratings for HBP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Helix BioPharma Corp. (HBP.TO) (TSE:HBP) Frequently Asked Questions

How has Helix BioPharma Corp. (HBP.TO)'s stock been impacted by Coronavirus (COVID-19)?

Helix BioPharma Corp. (HBP.TO)'s stock was trading at C$1.60 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, HBP shares have decreased by 81.9% and is now trading at C$0.29.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Helix BioPharma Corp. (HBP.TO)?

Wall Street analysts have given Helix BioPharma Corp. (HBP.TO) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Helix BioPharma Corp. (HBP.TO) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Helix BioPharma Corp. (HBP.TO)'s next earnings date?

Helix BioPharma Corp. (HBP.TO) is scheduled to release its next quarterly earnings announcement on Friday, December 11th 2020.
View our earnings forecast for Helix BioPharma Corp. (HBP.TO).

Who are some of Helix BioPharma Corp. (HBP.TO)'s key competitors?

Some companies that are related to Helix BioPharma Corp. (HBP.TO) include Horizon Discovery Group plc (HZD.L) (HZD), Arix Bioscience plc (ARIX.L) (ARIX), BiomX (PHGE), Actinium Pharmaceuticals (ATNM), Actinium Pharmaceuticals (ATNM), Mereo BioPharma Group plc (MPH.L) (MPH), Enochian Biosciences (ENOB), OncoCyte (OCX), OncoCyte (OCX), Exicure (XCUR), Exicure (XCUR), Verseon (VSN), ImmunoPrecise Antibodies Ltd. (IPA.V) (IPA), Equillium (EQ) and Eloxx Pharmaceuticals (ELOX).
View all competitors.

What other stocks do shareholders of Helix BioPharma Corp. (HBP.TO) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Helix BioPharma Corp. (HBP.TO) investors own include Lakeland Industries (LAKE), Liquidia Technologies (LQDA), Ovintiv (OVV), SIG plc (SHI.L) (SHI), The Green Organic Dutchman Holdings Ltd. (TGOD.TO) (TGOD), Zynerba Pharmaceuticals (ZYNE), American Airlines Group (AAL), Aurora Cannabis Inc. (ACB.TO) (ACB), Apollo Investment (AINV) and Aphria Inc. (APHA.TO) (APHA).

Who are Helix BioPharma Corp. (HBP.TO)'s key executives?

Helix BioPharma Corp. (HBP.TO)'s management team includes the following people:
  • Dr. Heman Chao, CEO, Chief Scientific Officer, Member of Scientific & Strategic Advisory Board and Director (Age 57, Pay $400.72k)
  • Mr. Photios Michalargias C.A., CPA, CPA, CA, Chief Financial Officer (Age 57, Pay $366.23k)
  • Mr. Pawel Wisniewski, Chief Exec. Officer of Poland

What is Helix BioPharma Corp. (HBP.TO)'s stock symbol?

Helix BioPharma Corp. (HBP.TO) trades on the Toronto Stock Exchange (TSX) under the ticker symbol "HBP."

How do I buy shares of Helix BioPharma Corp. (HBP.TO)?

Shares of HBP and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Helix BioPharma Corp. (HBP.TO)'s stock price today?

One share of HBP stock can currently be purchased for approximately C$0.29.

How big of a company is Helix BioPharma Corp. (HBP.TO)?

Helix BioPharma Corp. (HBP.TO) has a market capitalization of C$38.55 million. Helix BioPharma Corp. (HBP.TO) employs 22 workers across the globe.

What is Helix BioPharma Corp. (HBP.TO)'s official website?

The official website for Helix BioPharma Corp. (HBP.TO) is www.helixbiopharma.com.

How can I contact Helix BioPharma Corp. (HBP.TO)?

Helix BioPharma Corp. (HBP.TO)'s mailing address is 21 St Clair Ave E Suite 1100, TORONTO, ON M4T 1L9, Canada. The biopharmaceutical company can be reached via phone at +1-416-9253232.

This page was last updated on 12/2/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.